palmidrol has been researched along with oxidopamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avagliano, C; Boatto, G; Calignano, A; Luongo, E; Magliocca, S; Meli, R; Melisi, D; Nieddu, M; Orefice, NS; Raso, GM; Rimoli, MG; Russo, R; Santiago, GM; Santoro, A | 1 |
| Avagliano, C; Calignano, A; Citraro, R; Cristiano, C; De Caro, C; De Sarro, G; La Rana, G; Mattace Raso, G; Meli, R; Paciello, O; Piegari, G; Russo, E; Russo, R | 1 |
2 other study(ies) available for palmidrol and oxidopamine
| Article | Year |
|---|---|
Galactosyl prodrug of palmitoylethanolamide: synthesis, stability, cell permeation and cytoprotective activity.
Topics: Amides; Analgesics; Biological Transport; Cell Line, Tumor; Cell Survival; Cytoprotection; Drug Stability; Ethanolamines; Galactose; Humans; Hydrogen-Ion Concentration; Neuroprotective Agents; Nitrites; Oxidopamine; Palmitates; Palmitic Acids; Permeability; Prodrugs | 2014 |
Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence.
Topics: Amides; Animals; Apoptosis; Cell Death; Cyclooxygenase 2; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Endoplasmic Reticulum Stress; Ethanolamines; Male; Mice; Neuroblastoma; Neuroprotective Agents; Neurotoxicity Syndromes; Nitric Oxide Synthase; Oxidative Stress; Oxidopamine; Palmitic Acids; PPAR alpha; Reactive Oxygen Species; Superoxide Dismutase; Tyrosine 3-Monooxygenase | 2016 |